Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Rachel B Jones"'
Autor:
Simon Bond, Rachel B Jones, Rona M Smith, Kim Mynard, David R Jayne, Matthew Coates, Dominic Paul McGovern, Mark E McClure, Marcos Martinez Del Pero, Jacinta Lee, Menna Ruth Clatworthy
Publikováno v:
BMJ Open, Vol 14, Iss 7 (2024)
Introduction Relapses in ANCA-associated vasculitis (AAV) increase the incidence of end-organ damage and their prevention requires prolonged immunosuppressive therapy. Rituximab, a type I anti-CD20 B cell depleting monoclonal antibody, is the current
Externí odkaz:
https://doaj.org/article/439a1bae31204d01b880ed3f725a3132
Publikováno v:
RMD Open, Vol 5, Iss 1 (2019)
Introduction Eosinophilic granulomatosis with polyangiitis (EGPA) is a subset of antineutrophil cytoplasmic antibodies (ANCA) associated vasculitis with distinct pathophysiological mechanisms, clinical features and treatment responses. Rituximab is a
Externí odkaz:
https://doaj.org/article/f08a2bbfb59649b3a63bfe87c28b6852
Autor:
Rona M. Smith, Daniel J. Cooper, Rainer Doffinger, Hannah Stacey, Abdulrahman Al-Mohammad, Ian Goodfellow, Stephen Baker, Sara Lear, Myra Hosmilo, Nicholas Pritchard, Nicholas Torpey, David Jayne, Vivien Yiu, Anil Chalisey, Jacinta Lee, Enric Vilnar, Chee Kay Cheung, Rachel B. Jones
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Dialysis patients and immunosuppressed renal patients are at increased risk of COVID-19 and were excluded from vaccine trials. We conducted a prospective multicentre study to assess SARS-CoV-2 vaccine antibody responses in dialysi
Externí odkaz:
https://doaj.org/article/2e4719c10fc442a7b7d5dca898622e09
Autor:
Nicolas Benichou, Pierre Charles, Benjamin Terrier, Rachel B. Jones, Thomas Hiemstra, Luc Mouthon, Ingeborg Bajema, Annelies Berden, Eric Thervet, Loïc Guillevin, David Jayne, Alexandre Karras
Publikováno v:
Kidney International. 103:1144-1155
In anti-neutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV), hematuria and proteinuria are biomarkers reflecting kidney involvement at diagnosis. Yet, the prognostic value of their persistence after immunosuppressive induction therap
Autor:
Dominic McGovern, Rachel B Jones, Lisa C Willcocks, Rona M Smith, David R W Jayne, Andreas Kronbichler
Publikováno v:
Nephrology Dialysis Transplantation. 38:1067-1070
Autor:
Edward J Carr, Mary Wu, Ruth Harvey, Roseanne E Billany, Emma C Wall, Gavin Kelly, Michael Howell, George Kassiotis, Charles Swanton, Sonia Gandhi, David LV Bauer, Matthew PM Graham-Brown, Rachel B Jones, Rona M Smith, Stephen McAdoo, Michelle Willicombe, Rupert Beale
Publikováno v:
The Lancet. 399:800-802
Autor:
Rona M Smith, Rachel B Jones, Ulrich Specks, Simon Bond, Marianna Nodale, Reem Al-jayyousi, Jacqueline Andrews, Annette Bruchfeld, Brian Camilleri, Simon Carette, Chee Kay Cheung, Vimal Derebail, Tim Doulton, Alastair Ferraro, Lindsy Forbess, Shouichi Fujimoto, Shunsuke Furuta, Ora Gewurz-Singer, Lorraine Harper, Toshiko Ito-Ihara, Nader Khalidi, Rainer Klocke, Curry Koening, Yoshinori Komagata, Carol Langford, Peter Lanyon, Raashid Luqmani, Carol McAlear, Larry W Moreland, Kim Mynard, Patrick Nachman, Christian Pagnoux, Chen Au Peh, Charles Pusey, Dwarakanathan Ranganathan, Rennie L Rhee, Robert Spiera, Antoine G Sreih, Vladamir Tesar, Giles Walters, Caroline Wroe, David Jayne, Peter A Merkel
Publikováno v:
Annals of the Rheumatic Diseases. :ard-2022
ObjectiveFollowing induction of remission with rituximab in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) relapse rates are high, especially in patients with history of relapse. Relapses are associated with increased exposure to im
Publikováno v:
Clinical Kidney Journal
Vrije Universiteit Brussel
Vrije Universiteit Brussel
Background The disease course of adult immunoglobulin A (IgA) vasculitis (IgAV; Henoch–Schönlein purpura) has not been well defined. Methods In a retrospective survey, we studied 85 adult IgAV patients with extended follow-up (median 43 months) fo
Publikováno v:
Rheumatology. 60:iii67-iii69
Publikováno v:
Rheumatology. 60:iii47-iii49